N/A N=150 Gastric Procedures for Obesity
Morbid Obesity
Primary: Change in Body Weight — -21.4; -36.6; -7.0 kg
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=15 Assessment of Gastric Volume Reduction in Surgical Weight Loss Candidates
Obesity
Primary: Successful Gastric Plication Using Reduction Gastroplasty — 9; 6 participants
N/A N=355 Evaluation of Endostapled Anastomoses for Laparoscopic Gastric Bypass (EEA-LGB)
Morbid Obesity
Primary: Number of Participants With Postoperative Gastrointestinal Hemorrhage — 13; 39 participants
N/A N=20 Endoscopic Suturing for Primary Obesity Treatment
Obesity · Body Weight · Overweight
Primary: Number of Participants With Adverse Events — 5; 2; 0; 13 Participants
N/A N=4 Laparoscopic Sleeve Gastrectomy With Endoscopic Visualization
Morbid Obesity
Primary: Proportion of Procedures Completed With Successful Endoscopic Visualization. — 4 participants
N/A N=24 Endoscopic Surgery for Bariatric Revision After Weight Loss Failure
Morbid Obesity · Weight Loss
Primary: Mean Weight Loss — 13.3 Pounds
N/A N=100 Gastric Ultrasound
Surgery
Primary: Aspiration Risk Grade — 30; 30; 20; 9 Participants
N/A N=197 Laparoscopic Gastric Bypass vs LAP-BAND for Treatment of Morbid Obesity
Morbid Obesity
Primary: Excess Weight Loss From Pre-operation to 5 Years Post-operation — 68.4; 45.4 percent change
N/A N=208 Multicenter Endoscopic Sleeve Gastrectomy (ESG) Trial (MERIT Trial)
Obesity · Hypertension · Diabetes Mellitus, Type 2
Primary: Percentage of Excess Weight Loss (EWL) — 3.2; 49.2; 44.1 percentage of EWL
N/A N=63 Gastric Outlet Obstructions Tailored Covered Stents for GOO
Gastric Outlet Obstruction
Primary: Efficiency of Stents — 1; 7 participants
N/A N=30 Ileal Interposition With Sleeve Gastrectomy for Control of Diabetes
Diabetes
Primary: Percentage of Participants Having Remission of Type 2 Diabetes — 76.66 Percentage of Participants
N/A N=72 Randomized Comparison of Laparoscopic Sleeve Gastrectomy and Gastric Bypass for Morbid Obesity
Morbid Obesity · Metabolic Syndrome X · Diabetes Mellitus
Primary: Excess Weight Loss From Baseline — 67.8; 64.2 percentage of EWL
Phase 2 N=14 Evaluation of the Safety and Effectiveness of Stomaphyx for Transoral Incisionless Reduction of the Enlarged Gastric Pouch and Stoma
Morbid Obesity
Primary: Primary Outcome: Change in Body Weight — 9.6 kg
N/A N=35 Gastric Tissue Stapler Comparison Study
Gastric Resection
Primary: Pressure Evaluation — 126; 163 mmHg
N/A N=25 Use of Radiofrequency Ablation for RGB Salvage
Obesity
Primary: Excess Body Weight Loss After RFA Treatment — 28.36 percentage of EBWL
N/A N=10 Natural Orifice Transgastric Endoscopic (NOTES) Transgastric Diagnostic Peritoneoscopy With Laparoscopic Assistance
Abdominal Adhesions
Primary: Completion of Diagnostic Peritineoscopy — 8 Participants
N/A N=106 Endoscopic vs. Suction Device Calibration in Sleeve Gastrectomy
Gastrectomy · Obesity
Primary: Number of Staple Load Firings — 5.26; 5.42 Number of staples
N/A N=33 Taste Perception Pre and Post Bariatric Surgery
Morbid Obesity
Primary: Changes on Taste Detection Thresholds After Bariatric Surgery-induced Weight Loss (Roux-en-Y Gastric Bypass and Laparoscopic Adjustable Banding). — 7.5; 8.1; 6.5; 7.5…
N/A N=34 Food Preference Following Bariatric Surgery
Obesity
Primary: Total Food Intake (Lunch Buffet) at 24 Months — 2540.1; 721 kJ
N/A N=5 Gastric Artery Embolization Trial for Lessening Appetite Nonsurgically
Arterial Embolization · Other Surgical Procedures · Obesity
Primary: Body Weight Average 6 Months Post-Procedure — 237.6 lbs.
N/A N=30 Tri Staple Technology Stapler Used in Gastric Bypass
Sleep Apnea · Hypertension · Hyperlipidemia
Primary: Proportion of Patients With an Uneventful Creation of a Functional Staple Line — 28 participants
N/A N=53 Gastroesophageal Reflux Disease (GERD) Before and After Gastric Bypass
Gastroesophageal Reflux Disease · Morbid Obesity
Primary: Number of Participants Presenting Reflux Symptoms — 31; 8; 5 participants — p=<0.001
N/A N=62 Comparison Between Pyloric Preserving and Non-Pyloric Preserving Bariatric Surgery With Glucose Challenge
Hypoglycemia · Obesity
Primary: Mean Serum Glucose Levels — 123.1; 157.5; 103.2; 138 mg/dl
N/A N=39 Sonographic Evaluation of Visceral Fat After Bariatric Surgery
Morbid Obesity
Primary: Decrease in the Visceral Fat Layer Measured by Ultrasound a Day Before and a Year After Surgery. — 3.6; 7.1; 5.6 visceral fat reduction in centimeters
N/A N=240 Study of ECHELON ENDOPATH(TM) Staple Line Reinforcement
Gastric Procedures · Lung Resection Procedures
Primary: Number of Participants Who Experienced Specific Device-related Adverse Events (AEs) Through 70 Days Post Gastric Resection Procedures — 0; 1; 0 Participants
N/A N=60 Perianastomotic Drain After Gastrectomy (DRAG)
Gastric Cancer
Primary: a) Number of Participants With High Pain Levels (Using the Visual Analog Scale) — 31; 3 Participants
Phase 3 N=84 LapBand Adjustment to Improve Early Weight Loss
Obesity
Primary: %Excess Weight Loss 4-6 Weeks After Surgery (Large and Small Bands) — 15.63; 20.8 %EWL
N/A N=22 Diabetes and Gastric By- Pass
Type 2 Diabetes
Primary: Response in Glucose AUC at Baseline vs. Following Gastric Bypass Surgery — 61647.0; 59476.1 mg/dL*min
N/A N=9 Endoscopic Suturing System for Tissue Apposition
Obesity
Primary: Knotting Elements Placed — 11 elements
N/A N=44 The Lowering Weight in Severe Obesity by Embolization of the Gastric Artery Trial
Obesity, Morbid
Primary: Weight Loss — 2.8; 6.4; 1.8; 8.3 Percent change